INS and diabetes mellitus: They reported that elevated levels of glucose, free fatty acids, and inflammatory cytokines caused by diabetes and insulin resistance selectively inhibited insulin’s antiatherogenic actions via the IRS/PI3K/Akt pathway, but not the Grb/Shc/MAPK pathway.